
UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Helpful or harmful? The therapeutic potential of medications with varying degrees of abuse liability in the treatment of substance use disorders
Both ketamine and psychedelics may be useful in alcohol, cocaine & opioid use disorders.
Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample
Lifetime psilocybin use was associated with lowered odds of OUD.
Behavioral psychedelics: Integrating mind and behavior to improve health and resilience
the study of psychedelics to foster intentional changes in habits and behaviors to improve health and resilience.
Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings?
This commentary describes the ... potential impact of psychedelic-assisted psychotherapy on enhancing motivation to change in addiction treatment
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD
MDMA-AT for severe PTSD may also lead to subclinical improvements in alcohol use.
A systematic literature review of clinical trials and therapeutic applications of ibogaine
The published data suggest that ibogaine is an effective therapeutic intervention within the context of SUDs, reducing withdrawal symptoms and craving.
Most addiction specialists support legalized therapeutic psychedelics
The majority of US addiction specialists, including psychiatrists, believe psychedelics are promising for the treatment of substance use disorders.
Novel treatment approaches for substance use disorders: Therapeutic use of psychedelics and the role of psychotherapy
This review aims to discuss how psychedelics can promote and intensify psychotherapeutic key processes.
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting
Over study follow-up after adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use.
Use and abuse of dissociative and psychedelic drugs in adolescence.
Use and abuse of dissociative and psychedelic drugs in adolescence